Aurora Spine Corporation announced an increase of $200,000 to an existing loan from an insider, raising the total principal owed to $2.4 million. The loan carries a 4.5% annual interest rate and is due by July 11, 2029, with the option for early repayment without penalty. The funds will be used for general corporate purposes. This related party transaction is exempt from certain regulatory approvals but requires necessary conditions and approvals before completion.
Aurora Spine Corporation loan amendment news is provided with Pluang's Health sector market data for context. As of Sep 30, 2026 04:11 WIB, 42 of 100 Health-sector US stocks rose and 56 fell. Notable movers include Aurora Cannabis Inc (ACB) at USD 3.96 with a -3.18% change and a typical hold time of 26 days, Inovio Pharmaceuticals Inc (INO) at USD 1.14 with a -2.99% change and balanced Pluang order activity, and Teladoc Health Inc (TDOC) at USD 5.91 with a -2.96% change and a 39-day typical hold time.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Grass token briefly surged above $0.80, gaining over 25% in 24 hours following Multicoin Capital's investment. The DePIN project incentivizes users to share unused internet bandwidth, which is then used to process web data for AI labs. Grass plans to...
A wallet linked to Quant's founder transferred 25,776 QNT tokens valued at about $6.97 million after seven years of inactivity. The tokens were sent to several newly created wallets, while the original wallet still holds around 600,000 QNT tokens wor...
A wallet linked to Quant Network's founder moved 25,776 QNT tokens valued at $6.97 million after seven years of inactivity. The wallet still holds 600,000 QNT tokens worth $160.39 million. This transfer is significant in dollar terms but involves onl...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
